401 related articles for article (PubMed ID: 24378231)
21. Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis.
Rajasingham R; Meya DB; Greene GS; Jordan A; Nakawuka M; Chiller TM; Boulware DR; Larson BA
PLoS One; 2019; 14(1):e0210105. PubMed ID: 30629619
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of a point-of-care immunoassay test kit 'StrongStep' for cryptococcal antigen detection.
Mpoza E; Mukaremera L; Kundura DA; Akampurira A; Luggya T; Tadeo KK; Pastick KA; Bridge SC; Tugume L; Kiggundu R; Musubire AK; Williams DA; Muzoora C; Nalintya E; Rajasingham R; Rhein J; Boulware DR; Meya DB; Abassi M
PLoS One; 2018; 13(1):e0190652. PubMed ID: 29304090
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic Accuracy of the Biosynex CryptoPS Cryptococcal Antigen Semiquantitative Lateral Flow Assay in Patients with Advanced HIV Disease.
Tenforde MW; Boyer-Chammard T; Muthoga C; Tawe L; Milton T; Rulaganyang I; Lechiile K; Rukasha I; Leeme TB; Govender NP; Ngidi J; Mine M; Molloy SF; Harrison TS; Lortholary O; Jarvis JN
J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33087436
[TBL] [Abstract][Full Text] [Related]
24. A comparative evaluation of three methods for the rapid diagnosis of cryptococcal meningitis (CM) among HIV-infected patients in Northern Malawi.
Chisale MR; Salema D; Sinyiza F; Mkwaila J; Kamudumuli P; Lee HY
Malawi Med J; 2020 Mar; 32(1):3-7. PubMed ID: 32733652
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness of CRAG-LFA screening for cryptococcal meningitis among people living with HIV in Uganda.
Ramachandran A; Manabe Y; Rajasingham R; Shah M
BMC Infect Dis; 2017 Mar; 17(1):225. PubMed ID: 28335769
[TBL] [Abstract][Full Text] [Related]
26. Performance of the Lateral Flow Assay and the Latex Agglutination Serum Cryptococcal Antigen Test in Cryptococcal Disease in Patients with and without HIV.
Hevey MA; George IA; Rauseo AM; Larson L; Powderly W; Spec A
J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32848037
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic Accuracy of Point of Care Cryptococcal Antigen Lateral Flow Assay in Fingerprick Whole Blood and Urine Samples for the Detection of Asymptomatic Cryptococcal Disease in Patients with Advanced HIV Disease.
Boyd K; Kouamou V; Hlupeni A; Tangwena Z; Ndhlovu CE; Makadzange AT;
Microbiol Spectr; 2022 Aug; 10(4):e0107522. PubMed ID: 35924841
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic performance of the IMMY cryptococcal antigen lateral flow assay on serum and cerebrospinal fluid for diagnosis of cryptococcosis in HIV-negative patients: a systematic review.
Macrae C; Ellis J; Keddie SH; Falconer J; Bradley J; Keogh R; Baerenbold O; Hopkins H; Jarvis JN
BMC Infect Dis; 2023 Apr; 23(1):209. PubMed ID: 37024842
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of a Cryptococcal antigen Lateral Flow Assay in serum and cerebrospinal fluid for rapid diagnosis of cryptococcosis in Colombia.
Cáceres DH; Zuluaga A; Tabares ÁM; Chiller T; González Á; Gómez BL
Rev Inst Med Trop Sao Paulo; 2017 Dec; 59():e76. PubMed ID: 29267584
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of a Novel Semiquantitative Cryptococcal Antigen Lateral Flow Assay in Patients with Advanced HIV Disease.
Jarvis JN; Tenforde MW; Lechiile K; Milton T; Boose A; Leeme TB; Tawe L; Muthoga C; Rukasha I; Mulenga F; Rulaganyang I; Molefi M; Molloy SF; Ngidi J; Harrison TS; Govender NP; Mine M
J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32461286
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of Serum Cryptococcal Antigen Testing Using Two Novel Semiquantitative Lateral Flow Assays in Persons with Cryptococcal Antigenemia.
Skipper C; Tadeo K; Martyn E; Nalintya E; Rajasingham R; Meya DB; Kafufu B; Rhein J; Boulware DR
J Clin Microbiol; 2020 Mar; 58(4):. PubMed ID: 32024729
[TBL] [Abstract][Full Text] [Related]
32. Point-of-Care Testing for Cryptococcal Disease Among Hospitalized Human Immunodeficiency Virus-Infected Adults in Ethiopia.
Mamuye AT; Bornstein E; Temesgen O; Blumberg HM; Kempker RR
Am J Trop Med Hyg; 2016 Oct; 95(4):786-792. PubMed ID: 27527636
[TBL] [Abstract][Full Text] [Related]
33. Laboratory Reflex and Clinic-Based Point-of-Care Cryptococcal Antigen Screening for Preventing Meningitis and Mortality Among People Living With HIV.
Drain PK; Galagan SR; Govere S; Krows M; Thulare H; Wallis CL; Gosnell BI; Moosa MY; Celum C; Bassett IV
J Acquir Immune Defic Syndr; 2021 Aug; 87(5):1205-1213. PubMed ID: 33990495
[TBL] [Abstract][Full Text] [Related]
34. Low Cryptococcus Antigen Titers as Determined by Lateral Flow Assay Should Be Interpreted Cautiously in Patients without Prior Diagnosis of Cryptococcal Infection.
Dubbels M; Granger D; Theel ES
J Clin Microbiol; 2017 Aug; 55(8):2472-2479. PubMed ID: 28566315
[TBL] [Abstract][Full Text] [Related]
35. High Cryptococcal Antigen Titers in Blood Are Predictive of Subclinical Cryptococcal Meningitis Among Human Immunodeficiency Virus-Infected Patients.
Wake RM; Britz E; Sriruttan C; Rukasha I; Omar T; Spencer DC; Nel JS; Mashamaite S; Adelekan A; Chiller TM; Jarvis JN; Harrison TS; Govender NP
Clin Infect Dis; 2018 Feb; 66(5):686-692. PubMed ID: 29028998
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of cryptococcal infection among advanced HIV patients in Argentina using lateral flow immunoassay.
Frola C; Guelfand L; Blugerman G; Szyld E; Kaufman S; Cahn P; Sued O; Pérez H
PLoS One; 2017; 12(6):e0178721. PubMed ID: 28617817
[TBL] [Abstract][Full Text] [Related]
37. Clinical utility of the cryptococcal antigen lateral flow assay in a diagnostic mycology laboratory.
McMullan BJ; Halliday C; Sorrell TC; Judd D; Sleiman S; Marriott D; Olma T; Chen SC
PLoS One; 2012; 7(11):e49541. PubMed ID: 23166705
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the Biofire FilmArray meningitis/encephalitis assay for the detection of Cryptococcus neoformans/gattii.
Van TT; Kim TH; Butler-Wu SM
Clin Microbiol Infect; 2020 Oct; 26(10):1375-1379. PubMed ID: 31972318
[TBL] [Abstract][Full Text] [Related]
39. Integrating cryptococcal antigen screening and pre-emptive treatment into routine HIV care.
Rajasingham R; Meya DB; Boulware DR
J Acquir Immune Defic Syndr; 2012 Apr; 59(5):e85-91. PubMed ID: 22410867
[TBL] [Abstract][Full Text] [Related]
40. Investigation of CryptoPS LFA-positive sera in patients at risk of cryptococcosis.
Aissaoui N; Benhadid-Brahmi Y; Sturny-Leclère A; Hamane S; Payet E; Bonnal C; Munier AL; Denis B; Alanio A
Med Mycol; 2022 Oct; 60(10):. PubMed ID: 36149324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
